Zhu, Xingchen
An, Na
Tang, Zaixiang
Huang, Jianping
Ren, Qingxin
Wu, Yue
Funding for this research was provided by:
Nantong Health Commission (MS2022088)
National Natural Science Foundation of China (82373688, 81773541)
Jiangsu Province Engineering Research Center of Molecular Target Therapy and Companion Diagnostics in Oncology (SGK1202407)
Article History
Received: 3 July 2024
Accepted: 30 December 2024
First Online: 2 January 2025
Declarations
:
: This study was approved by the Ethics Committee of the Nantong City Disease Prevention and Control Center (approval no. 2023004). All methods were performed according to the Declaration of Helsinki and its future amendments. Written informed consent was obtained from all the participants and their parents or caregivers.
: Not applicable.
: The authors declare no competing interests.